Sarah Davis' daughter Emma was diagnosed with acute lymphoblastic leukaemia (ALL) as a 12-year-old. She writes about the support the family received and the progress Emma has made since finishing treatment
First formed to establish clinical trials in childhood cancer, research has always been an integral part of CCLG’s work. Ellie Ellicott, CCLG Research Communications Executive, tells us more about its research journey and how the experiences of those that matter the most are helping shape future directions.
Supportive care is an area of children’s cancer care that has progressed significantly in recent decades. Dr Bob Phillips and Dr Jess Morgan, members of CCLG’s Supportive Care working group, explain just some of the ways it has improved to help patients and their families cope with their disease and the treatment of it.
Naomi Shefford-Thomas, CCLG's Health Information Officer, discusses the importance of accessible information, how it works, and the steps CCLG is taking to make its health resources more inclusive and available to everyone.
Nicky Levent’s son, Sam, was diagnosed with retinoblastoma when he was 18 months old. She explains what it means to her family to raise funds for charities and awareness of childhood cancer, and how it’s helped them.
Child Cancer Smart is a public health intervention aiming to empower both the public and healthcare professionals with knowledge about childhood cancer symptoms. Dr Shaarna Shanmugavadivel, CCLG Research Fellow at the University of Nottingham and part of the project team, tells us more.
Lead investigator Susie Aldiss, a research fellow at the University of Surrey, discusses her research, which is funded by a £92,000 award from CCLG.
Sarah Dransfield was diagnosed with bone cancer in March 2012 aged 16. Here, she tells us what helped her during and after treatment and how cancer has changed her outlook on life.
Louise Graham is a clinical specialist paediatric physiotherapist at The Great North Children’s Hospital. She tells us about how she created a physical activity pathway to help children and young people (CYP) with acute lymphoblastic leukaemia (ALL) stay active, and how she hopes to develop this to support all CYP with cancer.
